121 related articles for article (PubMed ID: 2125056)
21. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
[TBL] [Abstract][Full Text] [Related]
22. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
23. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
24. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
[TBL] [Abstract][Full Text] [Related]
25. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.
Tanbo T; Dale PO; Lunde O; Norman N; Abyholm T
Fertil Steril; 1992 Apr; 57(4):819-24. PubMed ID: 1555694
[TBL] [Abstract][Full Text] [Related]
26. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
[TBL] [Abstract][Full Text] [Related]
27. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.
Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990
[TBL] [Abstract][Full Text] [Related]
28. Short-term use of buserelin in combination with human menopausal gonadotrophins for ovarian stimulation for in-vitro fertilization in endocrinologically normal women.
Smitz J; Bollen N; Camus M; Devroey P; Wisanto A; Van Steirteghem AC
Hum Reprod; 1990 Feb; 5(2):157-62. PubMed ID: 2108989
[TBL] [Abstract][Full Text] [Related]
29. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
30. The cycle characteristics of clomiphene with clomiphene and menotropins in polycystic ovary syndrome and non polycystic ovary syndrome infertile patients.
Ghasemi M; Ashraf H; Koushyar H; Mousavifar N
Minerva Ginecol; 2013 Jun; 65(3):311-7. PubMed ID: 23689174
[TBL] [Abstract][Full Text] [Related]
31. Effects of clomiphene citrate on serum hormone levels and endometrial thickness in an in vitro fertilization and embryo transfer program.
Saito H; Sato F; Hirayama T; Saito T; Yoh M; Hiroi M
Horm Res; 1991; 35 Suppl 1():39-44. PubMed ID: 1752603
[TBL] [Abstract][Full Text] [Related]
32. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
[TBL] [Abstract][Full Text] [Related]
33. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
34. Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF.
Ravhon A; Lavery S; Michael S; Donaldson M; Margara R; Trew G; Winston R
Hum Reprod; 2000 Nov; 15(11):2297-301. PubMed ID: 11056122
[TBL] [Abstract][Full Text] [Related]
35. Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
Crosignani PG; Maini MC; Negri E; Ragni G
Hum Reprod; 1991 Sep; 6(8):1070-3. PubMed ID: 1806563
[TBL] [Abstract][Full Text] [Related]
36. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.
Lee VC; Chan CC; Ng EH; Yeung WS; Ho PC
Reprod Biomed Online; 2011 Sep; 23(3):380-8. PubMed ID: 21782514
[TBL] [Abstract][Full Text] [Related]
37. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
38. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
Iwase A; Ando H; Kuno K; Mizutani S
Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
[TBL] [Abstract][Full Text] [Related]
39. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
40. Thorough sonographic oocyte retrieval during in vitro fertilization produces results similar to ovarian wedge resection in patients with clomiphene citrate-resistant polycystic ovarian syndrome.
Branigan EF; Estes A; Walker K; Rothgeb J
Am J Obstet Gynecol; 2006 Jun; 194(6):1696-700; discussion 1700-1. PubMed ID: 16731088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
